Confidential Information (CI): A Board-Level Risk Hiding in Plain Sight
For life sciences executives, intellectual property risk is typically framed around patents, exclusivity periods, and litigation exposure. Yet an increasing risk to enterprise value sits outside traditional IP modeling: the disclosure of commercially sensitive information through expanding regulatory transparency frameworks. As global regulators increase public access to clinical and regulatory submissions, disclosure is no longer [...]
5 Survival Lessons from the Life Sciences Coaching Trenches
As coaches and managers, we spend a lot of time and energy making sure our employees are okay. We worry about how to give feedback in a way that will build them up and give them confidence to grow. We worry about how to talk and listen effectively. We stay up at night strategizing how [...]
State Price Transparency Reporting Solution Checklist Download
This State Price Transparency Compliance Checklist helps life sciences organizations stay ahead of evolving state reporting requirements. Use it to assess your current readiness, identify compliance gaps, and take a more proactive approach to regulatory monitoring, reporting, and price change planning.
Why Life Sciences Companies Are Choosing Integrated SaaS Platforms Over Point Solutions to Ensure Compliant Growth
In today’s highly regulated, data-driven, and competitive life sciences environment, pharmaceutical, biotech, and medical device companies face increasing pressure to operate faster, more efficiently, and more intelligently. From commercial operations and regulatory compliance to supply chain management and financial planning, the number of business-critical processes that must work in harmony has never been greater. Traditionally, [...]
Medispend and RLDatix Life Sciences Complete Merger, Uniting Under the Medispend Brand to Create The Leading Life Sciences Compliance Software-as-a-Service Provider
PORTSMOUTH, Jan. 6, 2026 – Medispend and RLDatix Life Sciences today announced the successful completion of their merger, creating a unified organization that will operate under the Medispend name. The combined company offers a comprehensive suite of enterprise software and services for global regulatory and commercial compliance, medical affairs, field enablement and revenue management solutions [...]
State Price Transparency Solution Summary Download
Download our State Price Transparency Solution summary to see how MediSpend helps life sciences teams simplify state drug pricing transparency—from strategic drug price modeling to effortless end-to-end statutory reporting. You’ll learn how our platform supports comprehensive compliance tracking with real-time updates and a built-in compliance calendar, plus proactive legislative monitoring and forecasting to keep [...]
Making Sense of FMV: Strategies for the Life Sciences Industry
Introduction Fair Market Value (FMV) remains a central focus within the life sciences industry, as underscored at the recent Pharmaceutical and Medical Device Ethics and Compliance Congress. As the regulatory environment continues to evolve, companies are under increasing scrutiny regarding the appropriateness of compensation paid to healthcare professionals (HCPs). Corporate integrity agreements repeatedly highlight deficiencies [...]
MediSpend and Life Sciences Subsidiary of RLDatix Merge to Form Leading Global Provider of Regulatory and Compliance SaaS Solutions for Life Sciences
New company delivers built-for-purpose, best-in-class solutions spanning the entire product lifecycle for pharmaceutical, biotech, and medical device companies September 02, 2025 - MediSpend and RLDatix Life Sciences, a subsidiary of RLDatix, today announced a definitive agreement to merge, creating a new unified company at the forefront of life sciences innovation and compliance. The new company offers [...]
From Hot Mess to High-Performing: Building a Scalable Third-Party Due Diligence Program
Does your third-party due diligence process feel more like controlled chaos than a streamlined strategy? In today’s rapidly evolving regulatory landscape, life sciences organizations are struggling to balance comprehensive risk assessments with the need for speed, scale and cross-functional collaboration. In this insightful webinar we’ll guide you through transforming a fragmented third-party risk program [...]
MediSpend Acquires Alucio to Expand AI-Enabled Stakeholder Engagement Capabilities
Portsmouth, NH – August 4, 2025 — MediSpend, a global leading provider of compliance and stakeholder engagement solutions for the life sciences industry, announces its acquisition of Alucio, an innovative technology company known for its AI-enabled content management and HCP engagement platform, BEACON. The acquisition enhances MediSpend’s offerings to support more effective scientific exchanges between life [...]